Yuimedi
PrivateLast Round
Series A
Feb 18, 2026
Total Funding Raised
$9.59M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Yuimedi is a health-tech company that provides an AI-powered medical data infrastructure platform for cleansing, standardizing, and analyzing clinical datasets.
Sector
Healthcare & Life Sciences
Verticals
EHR & EMR, Healthcare Analytics, Data Integration, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Yuimedi Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Yuimedi Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Feb 18, 2026 | ||||
| Early Funding | Jul 2, 2024 | ||||
| Early Funding | Nov 30, 2022 | ||||
| Accelerator | Nov 29, 2022 |
Key People
Founding team and executive leadership
Yuimedi Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Darwin Venture Management | Series A |
| Sumitomo Mitsui Trust Bank | Series A |
| D4V (Design for Ventures) | Early Funding, Series A |
| Nissay Capital | Early Funding |
| DG Daiwa Ventures | Early Funding, Series A |
| Norinchukin Capital Co., Ltd. | Series A |
| Alchemist Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2026
Monthly visitors grew 103% MoM, reaching 5.5K.
Yuimedi Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Yuimedi's valuation, stock price, and market status.